Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines
Gisele Nishiguchi(St. Jude Children's Research Hospital), Zoran Ranković(St. Jude Children's Research Hospital), Danette L. Daniels(Foghorn Therapeutics (United States)), Yunchao Chang(St. Jude Children's Research Hospital), Lauren G. Mascibroda(St. Jude Children's Research Hospital), Junmin Peng(St. Jude Children's Research Hospital), Anthony A. High(St. Jude Children's Research Hospital), Shilpa Narina(St. Jude Children's Research Hospital), Darcie J. Miller(St. Jude Children's Research Hospital), Sourav Das(St. Jude Children's Research Hospital), Marcus Fischer(St. Jude Children's Research Hospital), Shondra M. Pruett‐Miller(St. Jude Children's Research Hospital), Sherif Abdelhamed(University of Washington Bothell), Kristin M. Riching(Promega (United States)), Ryan Hiltenbrand(St. Jude Children's Research Hospital), Jeffery M. Klco(St. Jude Children's Research Hospital), Vibhor Mishra(St. Jude Children's Research Hospital), Marjeta Urh(Promega (United States)), Kevin McGowan(St. Jude Children's Research Hospital), Charles G. Mullighan(St. Jude Children's Research Hospital), Suiping Zhou(St. Jude Children's Research Hospital), Kaiwen Yu(St. Jude Children's Research Hospital), Zhe Shi(Beijing University of Agriculture), Anand Mayasundari(St. Jude Children's Research Hospital), Melvin E. Thomas(St. Jude Children's Research Hospital), Allister J. Loughran(St. Jude Children's Research Hospital), Guido J.R. Zaman(GlaxoSmithKline (Netherlands)), Anang A. Shelat(St. Jude Children's Research Hospital), Jeffrey J. Kooijman, Juan M. Barajas(St. Jude Children's Research Hospital), Elizabeth A. Caine(Promega (United States)), Xusheng Wang(St. Jude Children's Research Hospital), Anup Aggarwal(St. Jude Children's Research Hospital), Sarah M. Young(St. Jude Children's Research Hospital), Ravi Kalathur(St. Jude Children's Research Hospital)
Cited by 50
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
|The Lancet Oncology|2009|1k